Hepatitis E: An emerging disease;L'hépatite virale E : Une maladie émergente

Revue de Medecine Interne

Volumn 33, Issue 6, 2012, Pages 328-334

  Bonnet, D ^a   Kamar, N ^b   Izopet, J ^a   Alric, L ^a  

^a CHU PURPAN   (France)

^b CHU RANGUEIL   (France)

Author keywords

Chronic hepatitis; Cirrhosis; Hepatitis E; Hepatitis E virus; Immunocompromised

Indexed keywords

HEPATITIS E VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RIBAVIRIN;

ACUTE HEPATITIS; BLOOD ANALYSIS; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; COMORBIDITY; DIAGNOSTIC ERROR; DOSE RESPONSE; ENDEMIC SPECIES; FECES ANALYSIS; GENOTYPE; GRAFT RECIPIENT; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOCOMPROMISED PATIENT; INDUSTRIALIZATION; LIVER CIRRHOSIS; LIVER FIBROSIS; LOW DRUG DOSE; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PREGNANT WOMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; SHORT SURVEY; TRAVEL; TREATMENT DURATION; VIRAL CLEARANCE; VIRUS DETECTION; VIRUS GENOME; VIRUS TRANSMISSION;

ADULT; AGED; COMMUNICABLE DISEASES, EMERGING; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; MALE; PREGNANCY; PREVALENCE; SEROLOGIC TESTS; YOUNG ADULT;

EID: 84862237504     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2012.01.017     Document Type: Short Survey

References (60)

1. Khuroo M.S. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 1980, 68:818-824.
2. Reyes G.R., Purdy M.A., Kim J.P., Luk K.C., Young L.M., Fry K.E., et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990, 247:1335-1339.
3. Aggarwal R., Jameel S. Hepatitis E. Hepatology 2011, 54:2218-2226.
4. Emerson S.U., Purcell R.H. Hepatitis E virus. Rev Med Virol 2003, 13:145-154.
5. Takahashi M., Tanaka T., Azuma M., Kusano E., Aikawa T., Shibayama T., et al. Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system. J Clin Microbiol 2007, 45:3671-3679.
6. Khuroo M.S., Kamili S., Dar M.Y., Moecklii R., Jameel S. Hepatitis E and long-term antibody status. Lancet 1993, 341:1355.
7. Abe K., Li T.C., Ding X., Win K.M., Shrestha P.K., Quang V.X., et al. International collaborative survey on epidemiology of hepatitis E virus in 11 countries. Southeast Asian J Trop Med Public Health 2006, 37:90-95.
8. Dalton H.R., Bendall R., Ijaz S., Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008, 8:698-709.
9. Fix A.D., Abdel-Hamid M., Purcell R.H., Shehata M.H., Abdel-Aziz F., Mikhail N., et al. Prevalence of antibodies to hepatitis E in two rural Egyptian communities. Am J Trop Med Hyg 2000, 62:519-523.
10. Shukla P., Chauhan U.K., Naik S., Anderson D., Aggarwal R. Hepatitis E virus infection among animals in northern India: an unlikely source of human disease. J Viral Hepat 2007, 14:310-317.
11. Aggarwal R., Naik S.R. Hepatitis E: intrafamilial transmission versus waterborne spread. J Hepatol 1994, 21:718-723.
12. Khuroo M.S., Kamili S., Yattoo G.N. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol 2004, 19:778-784.
13. Kumar A., Beniwal M., Kar P., Sharma J.B., Murthy N.S. Hepatitis E in pregnancy. Int J Gynaecol Obstet 2004, 85:240-244.
14. Khuroo M.S., Teli M.R., Skidmore S., Sofi M.A., Khuroo M.I. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981, 70:252-255.
15. Bhatia V., Singhal A., Panda S.K., Acharya S.K. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse?. Hepatology 2008, 48:1577-1585.
16. Navaneethan U., Al Mohajer M., Shata M.T. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int 2008, 28:1190-1199.
17. Zanetti A.R., Schlauder G.G., Romano L., Tanzi E., Fabris P., Dawson G.J., et al. Identification of a novel variant of hepatitis E virus in Italy. J Med Virol 1999, 57:356-360.
18. Mansuy J.M., Abravanel F., Miedouge M., Mengelle C., Merviel C., Dubois M., et al. Acute hepatitis E in south-west France over a 5-year period. J Clin Virol 2009, 44:74-77.
19. Kuniholm M.H., Purcell R.H., McQuillan G.M., Engle R.E., Wasley A., Nelson K.E. Epidemiology of hepatitis E virus in the United States: results from the third national health and nutrition examination survey, 1988-1994. J Infect Dis 2009, 200:48-56.
20. Dalton H.R., Stableforth W., Thurairajah P., Hazeldine S., Remnarace R., Usama W., et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008, 20:784-790.
21. Boutrouille A., Bakkali-Kassimi L., Cruciere C., Pavio N. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol 2007, 45:2009-2010.
22. Mansuy J.M., Legrand-Abravanel F., Calot J.P., Peron J.M., Alric L., Agudo S., et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 2008, 80:289-293.
23. Dalton H.R., Bendall R.P., Rashid M., Ellis V., Ali R., Ramnarace R., et al. Host risk factors and autochthonous hepatitis E infection. Eur J Gastroenterol Hepatol 2011, 23:1200-1205.
24. Meng X.J., Halbur P.G., Shapiro M.S., Govindarajan S., Bruna J.D., Mushahwar I.K., et al. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol 1998, 72:9714-9721.
25. Feagins A.R., Opriessnig T., Guenette D.K., Halbur P.G., Meng X.J. Detection and characterization of infectious hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J Gen Virol 2007, 88:912-917.
26. Legrand-Abravanel F., Kamar N., Sandres-Saune K., Garrouste C., Dubois M., Mansuy J.M., et al. Characteristics of autochthonous hepatitis E virus infection in solid organ transplant recipients in France. J Infect Dis 2010, 202:835-844.
27. Colson P., Borentain P., Queyriaux B., Kaba M., Moal V., Gallian P., et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010, 202:825-834.
28. Tamura A., Shimizu Y.K., Tanaka T., Kuroda K., Arakawa Y., Takahashi K., et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007, 37:113-120.
29. Kamar N., Abravanel F., Mansuy J.M., Peron J.M., Izopet J., Rostaing L. Hepatitis E infection in dialysis and after transplantation. Nephrol Ther 2010, 6:83-87.
30. Mast E.E., Alter M.J., Holland P.V., Purcell R.H. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E virus antibody serum panel evaluation group. Hepatology 1998, 27:857-861.
31. Peron J.M., Bureau C., Poirson H., Mansuy J.M., Alric L., Selves J., et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007, 14:298-303.
32. Kumar A.S., Kumar S.P., Singh R., Kumar M.S., Madan K., Kumar J.J., et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol 2007, 46:387-394.
33. Kamar N., Bendall R.P., Peron J.M., Cintas P., Prudhomme L., Mansuy J.M., et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011, 17:173-179.
34. Fourquet E., Mansuy J.M., Bureau C., Recher C., Vinel J.P., Izopet J., et al. Severe thrombocytopenia associated with acute autochthonous hepatitis E. J Clin Virol 2010, 48:73-74.
35. Alric L., Bonnet D., Laurent G., Kamar N., Izopet J. Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-alpha therapy. Ann Intern Med 2010, 20(153):135-136.
36. Au W.Y., Ngai C.W., Chan W.M., Leung R.Y., Chan S.C. Hemolysis and methemoglobinemia due to hepatitis E virus infection in patients with G6PD deficiency. Ann Hematol 2011, 90:1237-1238.
37. Mishra A., Saigal S., Gupta R., Sarin S.K. Acute pancreatitis associated with viral hepatitis: a report of six cases with review of literature. Am J Gastroenterol 1999, 94:2292-2295.
38. Peron J.M., Mansuy J.M., Recher C., Bureau C., Poirson H., Alric L., et al. Prolonged hepatitis E in an immunocompromised patient. J Gastroenterol Hepatol 2006, 21:1223-1224.
39. Haagsma E.B., van den Berg A.P., Porte R.J., Benne C.A., Vennema H., Reimerink J.H., et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008, 14:547-553.
40. Kamar N., Selves J., Mansuy J.M., Ouezzani L., Peron J.M., Guitard J., et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008, 358:811-817.
41. Dalton H.R., Bendall R.P., Keane F.E., Tedder R.S., Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009, 361:1025-1027.
42. Tavitian S., Peron J.M., Huynh A., Mansuy J.M., Ysebaert L., Huguet F., et al. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J Clin Virol 2010, 49:141-144.
43. Alric L., Bonnet D., Beynes-Rauzy O., Izopet J., Kamar N. Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. Am J Gastroenterol 2011, 106:1562-1563.
44. Kamar N., Abravanel F., Selves J., Garrouste C., Esposito L., Lavayssiere L., et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis E virus infection after organ transplantation. Transplantation 2010, 89:353-360.
45. Kamar N., Garrouste C., Haagsma E.B., Garrigue V., Pischke S., Chauvet C., et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011, 140:1481-1489.
46. Legrand-Abravanel F., Kamar N., Sandres-Saune K., Lhomme S., Mansuy J.M., Muscari F., et al. Hepatitis E virus infection without reactivation in solid organ transplant recipients, France. Emerg Infect Dis 2011, 17:30-37.
47. Le Coutre P., Meisel H., Hofmann J., Rocken C., Vuong G.L., Neuburger S., et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009, 58:699-702.
48. Schlosser B., Stein A., Neuhaus R., Pahl S., Ramez B., Kruger D.H., et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol 2012, 56(2):500-502.
49. Gonzalez Tallon A.I., Moreira V.V., Mateos Lindemann M.L., Achecar Justo L.M. Chronic hepatitis E in an immunocompetent patient. Gastroenterol Hepatol 2011, 34:398-400.
50. Legrand-Abravanel F., Thevenet I., Mansuy J.M., Saune K., Vischi F., Peron J.M., et al. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin Vaccine Immunol 2009, 16:772-774.
51. Lee W.M., Hynan L.S., Rossaro L., Fontana R.J., Stravitz R.T., Larson A.M., et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009, 137:856-864.
52. Haagsma E.B., Riezebos-Brilman A., van den Berg A.P., Porte R.J., Niesters H.G. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon-alpha-2b. Liver Transpl 2010, 16:474-477.
53. Kamar N., Rostaing L., Abravanel F., Garrouste C., Esposito L., Cardeau-Desangles I., et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010, 50:e30-e33.
54. Kamar N., Abravanel F., Garrouste C., Cardeau-Desangles I., Mansuy J.M., Weclawiak H., et al. Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. Nephrol Dial Transplant 2010, 25:2792-2795.
55. Mallet V., Nicand E., Sultanik P., Chakvetadze C., Tesse S., Thervet E., et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010, 20(153):85-89.
56. Kamar N., Rostaing L., Abravanel F., Garrouste C., Lhomme S., Esposito L., et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 2010, 139:1612-1618.
57. Dalton H.R., Keane F.E., Bendall R., Mathew J., Ijaz S. Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med 2011, 155:479-480.
58. Gerolami R., Borentain P., Raissouni F., Motte A., Solas C., Colson P. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011, 52:60-62.
59. Shrestha M.P., Scott R.M., Joshi D.M., Mammen M.P., Thapa G.B., Thapa N., et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007, 356:895-903.
60. Zhu F.C., Zhang J., Zhang X.F., Zhou C., Wang Z.Z., Huang S.J., et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010, 376:895-902.